These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 228761)

  • 21. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S; Edvinsson L; Olesen J; Kruuse C
    Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interaction between cyclic adenosine-3':5'-monophosphate phosphodiesterase and structural analogs of the substrate].
    Kochetkova MN; Guliaev NN; Tunitskaia VL; Severin ES
    Biokhimiia; 1981 Feb; 46(2):353-60. PubMed ID: 6264977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.
    Shepherd MC
    Pulm Pharmacol Ther; 2006; 19(1):24-31. PubMed ID: 16046159
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for a prejunctional role of cyclic nucleotides in neuromuscular transmission.
    Dretchen KL; Standaert FG; Skirboll LR; Morgenroth VH
    Nature; 1976 Nov; 264(5581):79-81. PubMed ID: 187946
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties of a cyclic 3'5'-nucleotide phosphodiesterase from Vigna mungo.
    Lee CH; Abidin UZ
    Biochem Int; 1989 Oct; 19(4):745-53. PubMed ID: 2559728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotonic actions of selective phosphodiesterase inhibitors in rat isolated ventricular cardiomyocytes.
    Kelso EJ; McDermott BJ; Silke B
    Br J Pharmacol; 1993 Dec; 110(4):1387-94. PubMed ID: 8306078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
    Onali P; Schwartz JP; Hanbauer I; Costa E
    Biochim Biophys Acta; 1981 Jul; 675(2):285-92. PubMed ID: 6268187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in intracellular pH accompanying chemoreception in the plasmodia of Physarum polycephalum.
    Hirose T; Ueda T; Kobatake Y
    J Gen Microbiol; 1982 Nov; 128(11):2647-51. PubMed ID: 7153759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phosphodiesterase assay using alumina microcolumns.
    Smith BJ; Wales MR; Jappy JW; Perry MJ
    Anal Biochem; 1993 Oct; 214(1):355-7. PubMed ID: 8250251
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
    Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
    Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of renal ecto-phosphodiesterase.
    Jackson EK; Ren J; Zacharia LC; Mi Z
    J Pharmacol Exp Ther; 2007 May; 321(2):810-5. PubMed ID: 17308037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of adenosine 3',5'-cyclic monophosphate derivatives on alpha-amylase release, protein kinase and cyclic nucleotide phosphodiesterase activity from rat parotid tissue.
    Butcher FR; Thayer M; Goldman JA
    Biochim Biophys Acta; 1976 Feb; 421(2):289-95. PubMed ID: 175844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase.
    Methven P; Lemon M; Bhoola K
    Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TVX 2706--a new phosphodiesterase inhibitor with antiinflammatory action. Biochemical characterization.
    Glaser T; Traber J
    Agents Actions; 1984 Oct; 15(3-4):341-8. PubMed ID: 6098174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.
    Tenor H; Hatzelmann A; Church MK; Schudt C; Shute JK
    Br J Pharmacol; 1996 Aug; 118(7):1727-35. PubMed ID: 8842438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing of mitosis in Physarum polycephalum: effects of agents affecting cyclic AMP concentrations.
    Trevithick JR; Braun R
    Experientia; 1977 Jan; 33(1):28-9. PubMed ID: 188679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective alteration of Ca2+-dependent and Ca2+-independent cyclic nucleotide phosphodiesterase activity in rat cerebral cortex by cyclic nucleotides and their analogs.
    Davis CW
    Biochim Biophys Acta; 1982 Jul; 705(1):1-7. PubMed ID: 6288105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.